Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 5
2018 6
2019 6
2020 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Bridging gaps between images and data: a systematic update on imaging biobanks.
Gabelloni M, Faggioni L, Borgheresi R, Restante G, Shortrede J, Tumminello L, Scapicchio C, Coppola F, Cioni D, Gómez-Rico I, Martí-Bonmatí L, Neri E. Gabelloni M, et al. Among authors: restante g. Eur Radiol. 2022 May;32(5):3173-3186. doi: 10.1007/s00330-021-08431-6. Epub 2022 Jan 10. Eur Radiol. 2022. PMID: 35001159 Review.
Implications of KRAS mutations in acquired resistance to treatment in NSCLC.
Del Re M, Rofi E, Restante G, Crucitta S, Arrigoni E, Fogli S, Di Maio M, Petrini I, Danesi R. Del Re M, et al. Among authors: restante g. Oncotarget. 2017 Dec 21;9(5):6630-6643. doi: 10.18632/oncotarget.23553. eCollection 2018 Jan 19. Oncotarget. 2017. PMID: 29464099 Free PMC article. Review.
Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment.
Del Re M, Crucitta S, Restante G, Rofi E, Arrigoni E, Biasco E, Sbrana A, Coppi E, Galli L, Bracarda S, Santini D, Danesi R. Del Re M, et al. Among authors: restante g. Crit Rev Oncol Hematol. 2018 May;125:51-59. doi: 10.1016/j.critrevonc.2018.03.002. Epub 2018 Mar 6. Crit Rev Oncol Hematol. 2018. PMID: 29650277 Review.
Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers.
Rofi E, Del Re M, Arrigoni E, Rizzo M, Fontanelli L, Crucitta S, Gianfilippo G, Restante G, Fogli S, Porta C, Danesi R, Schmidinger M. Rofi E, et al. Among authors: restante g. Crit Rev Oncol Hematol. 2020 Oct;154:102891. doi: 10.1016/j.critrevonc.2020.102891. Epub 2020 Apr 25. Crit Rev Oncol Hematol. 2020. PMID: 32340783 Free article.
20 results